H.‐G. Höffkes

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

Stefan Kubicka, Richard Greil, Thierry André et al. · Annals of Oncology · 2013 · 101 citations · Full text

Gastrointestinal Oncology, Medicine, Pathology +8

Enumeration of CD34-positive hematopoietic progenitor cells by flow cytometry: comparison of a volumetric assay and the ISHAGE gating strategy

S. Leuner, M. Arland, C. Kahl et al. · Bone Marrow Transplantation · 1998 · 30 citations

Flow Cytometry, Cell Therapy, Immunology +13

Multiparametric immunophenotyping of B cells in peripheral blood of healthy adults by flow cytometry

H.‐G. Höffkes, Gunter Schmidtke, M. Uppenkamp et al. · Clinical and Diagnostic Laboratory Immunology · 1996 · 27 citations

Prognostic significance of dysplastic features of hematopoiesis in patients with de novo acute myelogenous leukemia

C. Kahl, A. Florschütz, Gerd Müller et al. · Annals of Hematology · 1997 · 17 citations

Hematological Malignancy, Myelogenous Leukemia, Medicine +11

Bendamustine, Methotrexate, Mitoxantrone, and Prednisolone (BMMP) for the Treatment of Relapsed or Refractory High-Grade Non-Hodgkin’s Lymphoma

C. Kahl, Michael Herold, H.‐G. Höffkes et al. · Oncology Research and Treatment · 1997 · 16 citations